Skip to main content
. 2020 Oct 17;11(23):7009–7022. doi: 10.7150/jca.47895

Figure 2.

Figure 2

RRM2 expression in sub-groups of clinical characteristics. (A, B, F) RRM2 expression distribution analyses stratified based on age, gender, and M classification (Wilcoxon test). (C - E) RRM2 expression distribution analyses stratified based on tumor stage and TN classification (Kruskal-Wallis test). P-value < 0.05 was used to assess differences.